HIV-1 dual infection (DI) and CXCR4 (X4) coreceptor usage are associated with accelerated disease progression but frequency and dynamics of coreceptor usage during DI is unknown. Ultradeep sequencing was used to interrogate for DI and infer coreceptor usage in longitudinal blood samples of 102 subjects. At baseline, X4 usage was high (23 subjects harbored X4 variants) and was not associated with infection duration or DI. Coreceptor usage changed over time in 12 of 47 participants, and X4 usage emerged in 4 of 41 monoinfections vs 2 of 5 superinfections (P = .12), suggesting a weak statistical trend toward occurrence of superinfection and acquiring X4 usage.
Keywords: HIV-1 coinfection; HIV-1 dual infection; HIV-1 superinfection; coreceptor tropism; coreceptor usage; genotypic coreceptor usage prediction; genotypic tropism prediction; next-generation sequencing; ultradeep pyrosequencing.
Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.Antimicrob Agents Chemother. 2011 Jun;55(6):2831-6. doi: 10.1128/AAC.00091-11. Epub 2011 Apr 4. Antimicrob Agents Chemother. 2011. PMID: 21464245 Free PMC article.
Longitudinal ultradeep characterization of HIV type 1 R5 and X4 subpopulations in patients followed from primary infection to coreceptor switch.AIDS Res Hum Retroviruses. 2013 Sep;29(9):1237-44. doi: 10.1089/AID.2012.0349. Epub 2013 Jul 5. AIDS Res Hum Retroviruses. 2013. PMID: 23745959
Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.J Virol. 2016 Jul 27;90(16):7142-58. doi: 10.1128/JVI.00441-16. Print 2016 Aug 15. J Virol. 2016. PMID: 27226378 Free PMC article.
Genotypic coreceptor analysis.Eur J Med Res. 2007 Oct 15;12(9):453-62. Eur J Med Res. 2007. PMID: 17933727 Review.
Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.Eur J Med Res. 2007 Oct 15;12(9):463-72. Eur J Med Res. 2007. PMID: 17933728 Review.
Cited by 5 articles
Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM.Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012. eCollection 2016 Jan. Virus Evol. 2016. PMID: 30186625 Free PMC article.
Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.Front Med. 2017 Dec;11(4):480-489. doi: 10.1007/s11684-017-0594-8. Epub 2017 Nov 23. Front Med. 2017. PMID: 29170914 Free PMC article. Review.
Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.AIDS. 2017 May 15;31(8):1149-1158. doi: 10.1097/QAD.0000000000001445. AIDS. 2017. PMID: 28244954 Free PMC article.
Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.Sci Rep. 2015 Dec 3;5:17607. doi: 10.1038/srep17607. Sci Rep. 2015. PMID: 26631642 Free PMC article.
HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.Virology. 2015 Jan 1;474:34-40. doi: 10.1016/j.virol.2014.10.019. Epub 2014 Nov 11. Virology. 2015. PMID: 25463602 Free PMC article.
- K24 AI100665/AI/NIAID NIH HHS/United States
- MH83552/MH/NIMH NIH HHS/United States
- R01 AI047745/AI/NIAID NIH HHS/United States
- UM1 AI069432/AI/NIAID NIH HHS/United States
- AI080353/AI/NIAID NIH HHS/United States
- AI36214/AI/NIAID NIH HHS/United States
- MH097520/MH/NIMH NIH HHS/United States
- R21 AI047745/AI/NIAID NIH HHS/United States
- GM093939/GM/NIGMS NIH HHS/United States
- R01 GM093939/GM/NIGMS NIH HHS/United States
- U01 AI069432/AI/NIAID NIH HHS/United States
- AI74621/AI/NIAID NIH HHS/United States
- U01 AI043638/AI/NIAID NIH HHS/United States
- T32 AI007384/AI/NIAID NIH HHS/United States
- DP1 DA034978/DA/NIDA NIH HHS/United States
- R56 AI047745/AI/NIAID NIH HHS/United States
- R24 TW008908/TW/FIC NIH HHS/United States
- DA034978/DA/NIDA NIH HHS/United States
- P30 MH062512/MH/NIMH NIH HHS/United States
- R21 AI080353/AI/NIAID NIH HHS/United States
- MH62512/MH/NIMH NIH HHS/United States
- P30 AI036214/AI/NIAID NIH HHS/United States
- AI100665/AI/NIAID NIH HHS/United States
- R01 MH083552/MH/NIMH NIH HHS/United States
- U19 AI096113/AI/NIAID NIH HHS/United States
- TW008908/TW/FIC NIH HHS/United States
- R01 MH097520/MH/NIMH NIH HHS/United States
- AI43638/AI/NIAID NIH HHS/United States
- AI090970/AI/NIAID NIH HHS/United States
- U19 AI090970/AI/NIAID NIH HHS/United States
- AI47745/AI/NIAID NIH HHS/United States
- AI69432/AI/NIAID NIH HHS/United States
- P01 AI074621/AI/NIAID NIH HHS/United States
- AI096113/AI/NIAID NIH HHS/United States
- R24 AI106039/AI/NIAID NIH HHS/United States